2019 Annual Meeting | C109 - Neurology Update IV: Stroke, Neuro-infectious Disease, and Autoimmune Encephalopathies

Date Monday 05/06/19

Time 03:30 PM - 05:30 PM EDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Adam Quick, MD, Ralph F. Jozefowicz, MD, FAAN

Topic(s) Autoimmune Neurology, Cerebrovascular Disease and Interventional Neurology, Infectious Disease, General Neurology: Overview

Learning Objectives Participants should be able to apply new guidelines for acute stroke treatment, diagnose and treat the common neurological infectious diseases, and be able to recognize the clinical presentation and apply appropriate diagnostic tests for the identification of autoimmune encephalopathies.

CME Available 2.00 CME credits

Program Level Intermediate

Program Tracks Advanced Practice Provider

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Didactic

Program Materials Program Evaluations

Event Timeline
03:30 PM - 04:10 PM EDT	Speaker	Update in Stroke Amie W. Hsia, MD
04:10 PM - 04:50 PM EDT	Speaker	Update in Neuro-infectious Disease Kenneth L. Tyler, MD, FAAN
04:50 PM - 05:30 PM EDT	Speaker	Update in Autoimmune Encephalopathies Steven Vernino, MD, PhD, FAAN

Faculty Disclosures
Adam Quick, MD	The institution of Dr. Quick has received research support from NINDS. The institution of Dr. Quick has received research support from NEALS.
Ralph F. Jozefowicz, MD, FAAN	Dr. Jozefowicz has nothing to disclose.
Amie W. Hsia, MD	The institution of Dr. Hsia has received research support from NIH/NINDS.
Kenneth L. Tyler, MD, FAAN	Dr. Tyler has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Protagonist Therapeutics, Newark CA. Dr. Tyler has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Neurological Association/Wiley. Dr. Tyler has received intellectual property interests from a discovery or technology relating to health care. Dr. Tyler has received publishing royalties from a publication relating to health care. Dr. Tyler has a non-compensated relationship as a Director (ex officio) with American Neurological association that is relevant to AAN interests or activities. Dr. Tyler has a non-compensated relationship as a Director with International Society for Neurovirology that is relevant to AAN interests or activities.
Steven Vernino, MD, PhD, FAAN	Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for antag. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Autonomic Neuroscience (Elsevier). The institution of Dr. Vernino has received research support from Takeda. The institution of Dr. Vernino has received research support from NIH/NHLBI. The institution of Dr. Vernino has received research support from Dysautonomia International. Dr. Vernino has received personal compensation in the range of $10,000-$49,999 for serving as a Content Expert Consultant with Office of Inspector General for Medicare. Dr. Vernino has a non-compensated relationship as a Board of Directors with American Autonomic Society that is relevant to AAN interests or activities.

��ɫ��

��ɫ��